EUVIMEDEUVIMED entdecken
Crossref

Primary Adjunctive Corticosteroids in the Acute Management of High-Risk Kawasaki Disease in a North American Cohort

Alan P Wang iD, Huthaifah Khan, Siyuan Dong, Kwang-Youn A Kim iD, Pei-Ni Jone, Simon Lee, Stanford Shulman, Nancy Innocentini, Tresa Zielinski, Anne H Rowley

Journal of the Pediatric Infectious Diseases Society · 2024

DOI: 10.1093/jpids/piae112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2024. Verfasst von Alan P Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Mucocutaneous Lymph Node Syndrome, Immunoglobulins, Intravenous, Aspirin, Adrenal Cortex Hormones. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary adjunctive therapy with corticosteroids has been shown to reduce coronary artery (CA) abnormalities in high-risk Kawasaki disease (KD) patients in Japan (the randomized control trial to assess immunoglobulin plus steroid efficacy [RAISE] study). We evaluated their effect on outcomes in North American patients with high-risk KD.

Methods

We performed a single-center retrospective review of high-risk KD patients between 2010 and 2023. From 2017 to 2023, adjunctive corticosteroids in a modified RAISE regimen (mRAISE) were given to high-risk patients as primary adjunctive therapy with intravenous gammaglobulin (IVIG) and aspirin. We compared CA outcomes in these patients and those presenting from 2010 to 2016, when mRAISE therapy was not administered.

Results

A total of 221 high-risk KD patients were treated at our institution between 2010 and 2023. Among these, 83 received the mRAISE regimen and 138 did not (no corticosteroid, n = 82, corticosteroid in a non-mRAISE regimen, n = 56). There were no significant differences in CA outcomes in the mRAISE and non-mRAISE groups. Patients receiving the mRAISE regimen were significantly less likely to receive more than one dose of IVIG when compared to those who did not receive this regimen (11% vs 33%, p < .001).

Conclusions

Use of adjunctive primary therapy with corticosteroids in a mRAISE regimen in high-risk KD patients resulted in significantly decreased IVIG retreatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucocutaneous Lymph Node SyndromeImmunoglobulins, IntravenousAspirinAdrenal Cortex HormonesDrug Therapy, CombinationHumansRetrospective StudiesMaleFemaleChild, PreschoolInfantTreatment OutcomeChildNorth America

Stichwörter der Autor:innen

IVIG resistanceKawasaki diseaseRAISE protocolacute managementadjunctive corticosteroidshigh-risk

Substanzen

Immunoglobulins, IntravenousAspirinAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Alan P Wang, Kwang-Youn A Kim

Zitieren

APA

Wang, A. P., Khan, H., Dong, S., Kim, K. A., Jone, P. N., Lee, S., Shulman, S., Innocentini, N., Zielinski, T., & Rowley, A. H. (2024). Primary Adjunctive Corticosteroids in the Acute Management of High-Risk Kawasaki Disease in a North American Cohort. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piae112

Vancouver

Wang AP, Khan H, Dong S, Kim KA, Jone PN, Lee S, et al. Primary Adjunctive Corticosteroids in the Acute Management of High-Risk Kawasaki Disease in a North American Cohort. Journal of the Pediatric Infectious Diseases Society. 2024. doi:10.1093/jpids/piae112

BibTeX
@article{Wang2024,
  author = {Wang, Alan P and Khan, Huthaifah and Dong, Siyuan and Kim, Kwang-Youn A and Jone, Pei-Ni and Lee, Simon and Shulman, Stanford and Innocentini, Nancy and Zielinski, Tresa and Rowley, Anne H},
  title = {Primary Adjunctive Corticosteroids in the Acute Management of High-Risk Kawasaki Disease in a North American Cohort},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2024},
  doi = {10.1093/jpids/piae112}
}
Kostenlos starten →